Sirolimus as a new drug to treat RIF patients with elevated...

International Immunopharmacology 2019 / 09 Vol. 74

Sirolimus as a new drug to treat RIF patients with elevated Th17/Treg ratio: A double-blind, phase II randomized clinical trial

Ahmadi, Majid, Abdolmohamadi-vahid, Samaneh, Ghaebi, Mahnaz, Dolati, Sanam, Abbaspour-Aghdam, Sanaz, Danaii, Shahla, Berjis, Katayoun, Madadi-Javid, Rahime, Nouri, Zahra, Siahmansouri, Homayoon, Babal
How much do you like this book?
What’s the quality of the file?
Download the book for quality assessment
What’s the quality of the downloaded files?
Volume:
74
Language:
english
Journal:
International Immunopharmacology
DOI:
10.1016/j.intimp.2019.105730
Date:
September, 2019
File:
PDF, 1.37 MB
english, 2019
Conversion to is in progress
Conversion to is failed